Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Method Development for Determining the Removal of Metals from the Water Column under Transformation/Dissolution Conditions for Chronic Hazard Classification.

Huntsman P, Beaudoin R, Rader K, Carbonaro R, Burton GA Jr, Hudson M, Baken S, Garman E, Waeterschoot H.

Environ Toxicol Chem. 2019 May 17. doi: 10.1002/etc.4471. [Epub ahead of print]

PMID:
31099935
2.

Transformation/dissolution characterization of tungsten and tungsten compounds for aquatic hazard classification.

Huntsman P, Skeaff J, Pawlak M, Beaudoin R.

Integr Environ Assess Manag. 2018 Jul;14(4):498-508. doi: 10.1002/ieam.4040. Epub 2018 Mar 30.

PMID:
29464838
3.

Addressing aquatic hazard classification for metals, metal compounds and alloys in marine systems.

Huntsman-Mapila P, Skeaff JM, Pawlak M, Beaudoin R.

Mar Pollut Bull. 2016 Aug 15;109(1):550-557. doi: 10.1016/j.marpolbul.2016.03.055. Epub 2016 Jun 9.

PMID:
27289283
4.

OncDRS: An integrative clinical and genomic data platform for enabling translational research and precision medicine.

Orechia J, Pathak A, Shi Y, Nawani A, Belozerov A, Fontes C, Lakhiani C, Jawale C, Patel C, Quinn D, Botvinnik D, Mei E, Cotter E, Byleckie J, Ullman-Cullere M, Chhetri P, Chalasani P, Karnam P, Beaudoin R, Sahu S, Belozerova Y, Mathew JP.

Appl Transl Genom. 2015 Sep 14;6:18-25. doi: 10.1016/j.atg.2015.08.005. eCollection 2015 Sep.

5.

Étude des facteurs hospitaliers associés aux départs avant prise en charge médicale à l'urgence d'un centre hospitalier de soins tertiaires.

Elazhary N, Dolbec ML, Boucher T, Deshaies JF, Vanasse A, Beaudoin R.

CJEM. 2016 Jan;18(1):1-9. doi: 10.1017/cem.2015.101. Epub 2015 Nov 12. French. No abstract available.

PMID:
26558326
6.

Transformation/dissolution characteristics of a nickel matte and nickel concentrates for acute and chronic hazard classification.

Skeaff JM, Beaudoin R.

Integr Environ Assess Manag. 2015 Jan;11(1):130-42. doi: 10.1002/ieam.1573. Epub 2014 Nov 7.

PMID:
25103894
7.

Gating of spontaneous somatic sensations by movement.

Beaudoin R, Michael GA.

Somatosens Mot Res. 2014 Sep;31(3):111-21. doi: 10.3109/08990220.2014.888992. Epub 2014 Mar 5.

PMID:
24593828
8.

Transformation/dissolution examination of antimony and antimony compounds with speciation of the transformation/dissolution solutions.

Skeaff JM, Beaudoin R, Wang R, Joyce B.

Integr Environ Assess Manag. 2013 Jan;9(1):98-113. doi: 10.1002/ieam.1339. Epub 2012 Oct 17.

PMID:
22791698
9.

Comparative potency approach based on H2AX assay for estimating the genotoxicity of polycyclic aromatic hydrocarbons.

Audebert M, Zeman F, Beaudoin R, Péry A, Cravedi JP.

Toxicol Appl Pharmacol. 2012 Apr 1;260(1):58-64. doi: 10.1016/j.taap.2012.01.022. Epub 2012 Jan 30.

PMID:
22306620
10.

Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding.

McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y, Tsung EF, Clouser CR, Duncan C, Ichikawa JK, Lee CC, Zhang Z, Ranade SS, Dimalanta ET, Hyland FC, Sokolsky TD, Zhang L, Sheridan A, Fu H, Hendrickson CL, Li B, Kotler L, Stuart JR, Malek JA, Manning JM, Antipova AA, Perez DS, Moore MP, Hayashibara KC, Lyons MR, Beaudoin RE, Coleman BE, Laptewicz MW, Sannicandro AE, Rhodes MD, Gottimukkala RK, Yang S, Bafna V, Bashir A, MacBride A, Alkan C, Kidd JM, Eichler EE, Reese MG, De La Vega FM, Blanchard AP.

Genome Res. 2009 Sep;19(9):1527-41. doi: 10.1101/gr.091868.109. Epub 2009 Jun 22.

11.

"We are all in this together": integrated health service plans in Ontario.

Eliasoph H, Monaghan B, Beaudoin R, Cushman R, DuBois-Wing G, Emery MJ, Fenn WM, Hanmer SJ, Huras P, Lowi-Young M, Mandy P, Trimnell J, Switzer G, Woolgar T, Butler J.

Healthc Q. 2007;10(3):82-7.

12.

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.

Charoenvit Y, Mellouk S, Sedegah M, Toyoshima T, Leef MF, De la Vega P, Beaudoin RL, Aikawa M, Fallarme V, Hoffman SL.

Exp Parasitol. 1995 May;80(3):419-29.

PMID:
7729477
13.

Activation of the renal renin-angiotensin system by cyclosporine A and FK 506 in the rat.

Kupferman JC, Beaudoin R, Carr R, Hay D, Casellas D, Kaskel FJ, Moore LC.

Transplant Proc. 1994 Oct;26(5):2891-3. No abstract available.

PMID:
7524224
14.

Effects of transmission-blocking immunity on Plasmodium vivax infections in Anopheles albimanus populations.

Ramsey JM, Salinas E, Rodriguez MH, Beaudoin RL.

J Parasitol. 1994 Feb;80(1):88-92.

PMID:
8308663
15.
16.

Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity.

Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD, Houghten RA, Beaudoin RL, Smith D, Hoffman SL.

Vaccine. 1992;10(9):578-84.

PMID:
1323900
17.

Antigenic analysis of Plasmodium yoelii liver stages by fluorescence antibody assays.

Londoño JA, Sedegah M, Charoenvit Y, Beaudoin RL, Druilhe P.

Trop Med Parasitol. 1991 Dec;42(4):381-5.

PMID:
1724570
18.

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.

Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL.

Science. 1991 May 3;252(5006):715-8.

PMID:
1827210
19.

Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.

Charoenvit Y, Collins WE, Jones TR, Millet P, Yuan L, Campbell GH, Beaudoin RL, Broderson JR, Hoffman SL.

Science. 1991 Feb 8;251(4994):668-71.

PMID:
1704150
20.

Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.

Charoenvit Y, Mellouk S, Cole C, Bechara R, Leef MF, Sedegah M, Yuan LF, Robey FA, Beaudoin RL, Hoffman SL.

J Immunol. 1991 Feb 1;146(3):1020-5.

PMID:
1988490
21.

Evaluation of monoclonal antibodies against Plasmodium vivax sporozoites for ELISA development.

Wirtz RA, Charoenvit Y, Burkot TR, Esser KM, Beaudoin RL, Collins WE, Andre RG.

Med Vet Entomol. 1991 Jan;5(1):17-22.

PMID:
1768896
22.

Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans.

Rickman LS, Jones TR, Long GW, Paparello S, Schneider I, Paul CF, Beaudoin RL, Hoffman SL.

Am J Trop Med Hyg. 1990 Nov;43(5):441-5.

PMID:
2240371
23.

Protection against malaria induced by irradiated sporozoites.

Mellouk S, Lunel F, Sedegah M, Beaudoin RL, Druilhe P.

Lancet. 1990 Mar 24;335(8691):721. No abstract available.

PMID:
1969073
24.

Localization of CS and non-CS antigens in the sporogonic stages of Plasmodium yoelii.

Aikawa M, Atkinson CT, Beaudoin LM, Sedegah M, Charoenvit Y, Beaudoin R.

Bull World Health Organ. 1990;68 Suppl:165-71.

25.

A malaria sporozoite surface antigen distinct from the circumsporozoite protein.

Hedstrom RC, Campbell JR, Leef ML, Charoenvit Y, Carter M, Sedegah M, Beaudoin RL, Hoffman SL.

Bull World Health Organ. 1990;68 Suppl:152-7.

26.

Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene.

Sedegah M, Beaudoin RL, Majarian WR, Cochran MD, Chiang CH, Sadoff J, Aggarwal A, Charoenvit Y, Hoffman SL.

Bull World Health Organ. 1990;68 Suppl:109-14.

27.

Active and passive immunization against Plasmodium yoelii sporozoites.

Charoenvit Y, Sedegah M, Yuan LF, Gross M, Cole C, Bechara R, Leef MF, Robey FA, Lowell GH, Beaudoin RL.

Bull World Health Organ. 1990;68 Suppl:26-32.

28.

Freeze-fracture studies on the sporoblast and sporozoite development in the early oocyst.

Meszoely CA, Erbe EF, Beaudoin LM, Beaudoin RL.

Am J Trop Med Hyg. 1989 Nov;41(5):499-503.

PMID:
2683819
29.

Dual action of anti-sporozoite antibodies in vitro.

Nudelman S, Rénia L, Charoenvit Y, Yuan L, Miltgen F, Beaudoin RL, Mazier D.

J Immunol. 1989 Aug 1;143(3):996-1000.

PMID:
2745980
30.

Cloning of Plasmodium yoelii genes expressing three different sporozoite-specific antigens.

Wortman A, Rogers P, Charoenvit Y, McDermott A, Leef M, Sedegah M, Beaudoin RL.

Microb Pathog. 1989 Mar;6(3):227-31.

PMID:
2472543
31.

The use of dextran as a blocking agent on nitrocellulose membrane in the analysis of sporozoite antigens of Plasmodium vivax.

Yuan LF, Wirtz RA, Beaudoin RL.

J Biochem Biophys Methods. 1988 Oct;17(2):135-42.

PMID:
2464018
32.

Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.

Stahel E, Mazier D, Guillouzo A, Miltgen F, Landau I, Mellouk S, Beaudoin RL, Langlois P, Gentilini M.

Am J Trop Med Hyg. 1988 Sep;39(3):236-40.

PMID:
3052118
33.

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF.

Proc Natl Acad Sci U S A. 1988 Jan;85(2):573-6.

34.

Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures.

Mellouk S, Maheshwari RK, Rhodes-Feuillette A, Beaudoin RL, Berbiguier N, Matile H, Miltgen F, Landau I, Pied S, Chigot JP, et al.

J Immunol. 1987 Dec 15;139(12):4192-5.

PMID:
2447163
35.

A rapid method for screening antibodies to Plasmodium yoelii liver stages by immunofluorescence.

Sedegah M, Leef MF, Matheny S, Beaudoin RL.

J Parasitol. 1987 Dec;73(6):1268-70. No abstract available.

PMID:
3325624
36.

Plasmodium falciparum: freeze-fracture of the gametocyte pellicular complex.

Meszoely CA, Erbe EF, Steere RL, Trosper J, Beaudoin RL.

Exp Parasitol. 1987 Dec;64(3):300-9.

PMID:
3315730
37.

A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.

Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G.

Nature. 1987 Sep 10-16;329(6135):164-7.

PMID:
3306406
38.

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens.

Charoenvit Y, Leef MF, Yuan LF, Sedegah M, Beaudoin RL.

Infect Immun. 1987 Mar;55(3):604-8.

39.

Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development.

Wirtz RA, Zavala F, Charoenvit Y, Campbell GH, Burkot TR, Schneider I, Esser KM, Beaudoin RL, Andre RG.

Bull World Health Organ. 1987;65(1):39-45.

40.
41.

Field trial in Chiapas, Mexico, of a rapid detection method for malaria in anopheline vectors with low infection rates.

Ramsey JM, Bown DN, Aron JL, Beaudoin RL, Mendez JF.

Am J Trop Med Hyg. 1986 Mar;35(2):234-8.

PMID:
3513640
42.

Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.

Mazier D, Mellouk S, Beaudoin RL, Texier B, Druilhe P, Hockmeyer W, Trosper J, Paul C, Charoenvit Y, Young J, et al.

Science. 1986 Jan 10;231(4734):156-9.

PMID:
3510455
43.

Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax.

McCutchan TF, Lal AA, de la Cruz VF, Miller LH, Maloy WL, Charoenvit Y, Beaudoin RL, Guerry P, Wistar R Jr, Hoffman SL, et al.

Science. 1985 Dec 20;230(4732):1381-3.

PMID:
2416057
44.

Absence of correlation between the degree of alveolitis and antibody levels to Micropolysporum faeni.

Hébert J, Beaudoin J, Laviolette M, Beaudoin R, Bélanger J, Cormier Y.

Clin Exp Immunol. 1985 Jun;60(3):572-8.

45.

Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.

Ballou WR, Rothbard J, Wirtz RA, Gordon DM, Williams JS, Gore RW, Schneider I, Hollingdale MR, Beaudoin RL, Maloy WL, et al.

Science. 1985 May 24;228(4702):996-9.

PMID:
2988126
46.

Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.

Young JF, Hockmeyer WT, Gross M, Ballou WR, Wirtz RA, Trosper JH, Beaudoin RL, Hollingdale MR, Miller LH, Diggs CL, et al.

Science. 1985 May 24;228(4702):958-62.

PMID:
2988125
47.

Complete development of hepatic stages of Plasmodium falciparum in vitro.

Mazier D, Beaudoin RL, Mellouk S, Druilhe P, Texier B, Trosper J, Miltgen F, Landau I, Paul C, Brandicourt O, et al.

Science. 1985 Jan 25;227(4685):440-2.

PMID:
3880923
48.

Abnormal bronchoalveolar lavage in asymptomatic dairy farmers. Study of lymphocytes.

Cormier Y, Bélanger J, Beaudoin J, Laviolette M, Beaudoin R, Hebert J.

Am Rev Respir Dis. 1984 Dec;130(6):1046-9.

PMID:
6508002
49.

The regulatory effect of histamine on the immune response: III. Defect on in vitro IgE production in atopics.

Hebert J, Beaudoin R, Girard M, Beaulieu A, Perelmutter L, Tremblay C.

Ann Allergy. 1984 Aug;53(2):138-42.

PMID:
6235759
50.

Etude polarographique du niobium dans les melanges eau-fluorure d'hydrogene en presence d'ions tetraalkylammonium.

Menard H, Beaudoin R.

Talanta. 1984 Jun;31(6):417-20. French. No abstract available.

PMID:
18963622

Supplemental Content

Loading ...
Support Center